Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05158985 |
Other study ID # |
6786 |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 15, 2020 |
Est. completion date |
November 1, 2022 |
Study information
Verified date |
December 2021 |
Source |
October 6 University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Lateral epicondylitis is a tendinopathy injury involving the extensor muscles of the forearm.
These muscles originate on the lateral epicondylar region of the distal humerus. the
insertion of the extensor carpi radialis brevis is involved in most cases. Transdermal
administration of an anti-inflammatory drug to specific area is one of the methods that used
to decrease inflammation and increase cell metabolism
Description:
Lateral epicondylitis is a soft-tissue lesion of the tendinous origin of the wrist extensor
muscles at their origin on the lateral humeral epicondyle. The extensor carpi radialis brevis
is the area of most pathologic changes. It begins as a microtear of the tendinous origin of
the wrist extensor muscles and results in degeneration and reactive granulation tissue
formation. Activities involving prolonged or repeated gripping, wrist extension, forearm
supination, and pronation cause eventual failure of the affected portion of the tendon. The
mechanical failure of the tendon results in an ensuring tendinitis and symptoms of lateral
epicondylitis. It is aggravated with movements of the wrist, by palpation of the lateral side
of elbow, or by contraction of extensor muscles of the wrist.
There are different treatment methods for lateral epicondylitis. Initially, lateral
epicondylitis has been treated with ice, rest, counterforce tennis brace and/or non-steroidal
anti-inflammatory drugs. But when the condition is not responding to initial treatment
physical therapy is initiated